Bio Path OTC Stock Forecast - Simple Regression
| BPTH Stock | USD 0.07 0.01 11.67% |
The Simple Regression forecasted value of Bio Path Holdings on the next trading day is expected to be 0.05 with a mean absolute deviation of 0.01 and the sum of the absolute errors of 0.34. Bio OTC Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Bio Path's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 23rd of January 2026, the value of RSI of Bio Path's share price is approaching 49 suggesting that the otc stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Bio Path, making its price go up or down. Momentum 49
Impartial
Oversold | Overbought |
It is a matter of debate whether otc price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Bio Path based on different types of headlines from major news networks to social media. Using Bio Path hype-based prediction, you can estimate the value of Bio Path Holdings from the perspective of Bio Path response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Regression forecasted value of Bio Path Holdings on the next trading day is expected to be 0.05 with a mean absolute deviation of 0.01 and the sum of the absolute errors of 0.34. Bio Path after-hype prediction price | USD 0.07 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Bio |
Bio Path Additional Predictive Modules
Most predictive techniques to examine Bio price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Bio using various technical indicators. When you analyze Bio charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Bio Path Simple Regression Price Forecast For the 24th of January
Given 90 days horizon, the Simple Regression forecasted value of Bio Path Holdings on the next trading day is expected to be 0.05 with a mean absolute deviation of 0.01, mean absolute percentage error of 0.000047, and the sum of the absolute errors of 0.34.Please note that although there have been many attempts to predict Bio OTC Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Bio Path's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Bio Path OTC Stock Forecast Pattern
| Backtest Bio Path | Bio Path Price Prediction | Buy or Sell Advice |
Bio Path Forecasted Value
In the context of forecasting Bio Path's OTC Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Bio Path's downside and upside margins for the forecasting period are 0.0007 and 9.73, respectively. We have considered Bio Path's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Bio Path otc stock data series using in forecasting. Note that when a statistical model is used to represent Bio Path otc stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 109.973 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0055 |
| MAPE | Mean absolute percentage error | 0.0758 |
| SAE | Sum of the absolute errors | 0.3403 |
Predictive Modules for Bio Path
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bio Path Holdings. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bio Path's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bio Path After-Hype Price Prediction Density Analysis
As far as predicting the price of Bio Path at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Bio Path or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of Bio Path, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Bio Path Estimiated After-Hype Price Volatility
In the context of predicting Bio Path's otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Bio Path's historical news coverage. Bio Path's after-hype downside and upside margins for the prediction period are 0.00 and 10.20, respectively. We have considered Bio Path's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Bio Path is out of control at this time. Analysis and calculation of next after-hype price of Bio Path Holdings is based on 3 months time horizon.
Bio Path OTC Stock Price Prediction Analysis
Have you ever been surprised when a price of a OTC Stock such as Bio Path is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bio Path backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Bio Path, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.20 | 9.68 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.07 | 0.07 | 4.48 |
|
Bio Path Hype Timeline
Bio Path Holdings is currently traded for 0.07. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Bio is anticipated to increase in value after the next headline, with the price projected to jump to 0.07 or above. The average volatility of media hype impact on the company the price is insignificant. The price growth on the next news is projected to be 4.48%, whereas the daily expected return is currently at -0.2%. The volatility of related hype on Bio Path is about 0.0%, with the expected price after the next announcement by competition of 0.07. Bio Path Holdings currently holds about 17.02 M in cash with (11.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.38, which can makes it an attractive takeover target, given it will continue generating positive cash flow. Given the investment horizon of 90 days the next anticipated press release will be in 5 to 10 days. Check out Historical Fundamental Analysis of Bio Path to cross-verify your projections.Bio Path Related Hype Analysis
Having access to credible news sources related to Bio Path's direct competition is more important than ever and may enhance your ability to predict Bio Path's future price movements. Getting to know how Bio Path's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Bio Path may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ORGS | Orgenesis | 0.00 | 0 per month | 32.60 | 0.26 | 341.18 | (77.33) | 572.08 | |
| EMMA | Emmaus Life Sciences | 0.00 | 0 per month | 6.99 | 0.06 | 20.37 | (15.45) | 64.24 | |
| SQZB | SQZ Biotechnologies | 0.00 | 0 per month | 0.00 | (0.05) | 3.45 | (4.17) | 50.43 | |
| HXBM | Helix BioMedix | 0.00 | 0 per month | 0.00 | (0.21) | 0.00 | 0.00 | 25.93 | |
| IDCN | Indocan Resources | 0.00 | 2 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PAIOF | Paion AG | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ELLXF | Elixinol Global | 0.00 | 0 per month | 29.61 | 0.25 | 222.22 | (69.37) | 323.40 | |
| YECO | Yulong Eco Materials | 0.00 | 0 per month | 0.00 | (0.01) | 0.00 | 0.00 | 42.46 | |
| UNBX | Unity Biotechnology | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| VIBEF | Vibe Growth | 0.00 | 1 per month | 0.00 | (0.02) | 15.00 | (13.04) | 61.59 |
Other Forecasting Options for Bio Path
For every potential investor in Bio, whether a beginner or expert, Bio Path's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Bio OTC Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Bio. Basic forecasting techniques help filter out the noise by identifying Bio Path's price trends.Bio Path Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bio Path otc stock to make a market-neutral strategy. Peer analysis of Bio Path could also be used in its relative valuation, which is a method of valuing Bio Path by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Bio Path Market Strength Events
Market strength indicators help investors to evaluate how Bio Path otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bio Path shares will generate the highest return on investment. By undertsting and applying Bio Path otc stock market strength indicators, traders can identify Bio Path Holdings entry and exit signals to maximize returns.
| Accumulation Distribution | 108.51 | |||
| Daily Balance Of Power | 0.5556 | |||
| Rate Of Daily Change | 1.12 | |||
| Day Median Price | 0.0607 | |||
| Day Typical Price | 0.0628 | |||
| Price Action Indicator | 0.0098 | |||
| Period Momentum Indicator | 0.007 | |||
| Relative Strength Index | 49.84 |
Bio Path Risk Indicators
The analysis of Bio Path's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Bio Path's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting bio otc stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 6.37 | |||
| Semi Deviation | 7.07 | |||
| Standard Deviation | 10.55 | |||
| Variance | 111.27 | |||
| Downside Variance | 244.3 | |||
| Semi Variance | 49.99 | |||
| Expected Short fall | (18.21) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Bio Path
The number of cover stories for Bio Path depends on current market conditions and Bio Path's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Bio Path is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Bio Path's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Bio Path Short Properties
Bio Path's future price predictability will typically decrease when Bio Path's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Bio Path Holdings often depends not only on the future outlook of the potential Bio Path's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bio Path's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 478 K | |
| Cash And Short Term Investments | 1.1 M |
Other Information on Investing in Bio OTC Stock
Bio Path financial ratios help investors to determine whether Bio OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bio with respect to the benefits of owning Bio Path security.